Fecal Incontinence: Epidemiology & Burden of Illness

Lucinda Harris, MD
Mayo Clinic
Scottsdale, AZ

Didactic Lecture

Viewing Options

Webcast

Topic Information

Target Audience

This enduring activity has been designed to meet the educational needs of gastroenterologists, colorectal surgeons, urogynecologists, physician assistants, nurse practitioners and nurses involved in the care of patients with fecal incontinence.

Goal Statement

This program will focus on the diagnosis and management of fecal incontinence, with the goal of improving recognition, identification of underlying factors, and treatment.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Describe the prevalence of fecal incontinence overall and the prevalence of fecal incontinence subtypes

Identify key treatments for fecal incontinence, including nonpharmacologic and interventional modalities

Credit Designation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower and Gi Health Foundation.

The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

A maximum of 0.5 contact hours may be earned for successful completion of this enduring material.

Provider is approved by the California Board of Registered Nursing, Provider #13664, for 0.5 contact hours.

Disclosure of Conflicts of Interest

All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education (ACHS), consults for Pfizer, Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower and The Gi Health Foundation has no relationships to disclose.

Learner Assurance Statement

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Lucinda Harris, MD, has served as a consultant for and has participated on the speakers bureau for bureau for Salix Pharmaceuticals, Inc., Forest Pharmaceuticals, Inc., and Ironwood Pharmaceuticals, Inc. Dr. Harris has served as an advisory board member for Dyax Corp., Forest Laboratories, Inc., and Ironwood Pharmaceuticals, Inc., Takeda Pharmaceuticals and Sucampo Pharmaceuticals, Inc.

Release Date: September 1, 2014Expiration Date: September 1, 2015   
*This program has expired. CME credit is no longer available.

This activity is supported by an educational grant from Salix Pharmaceuticals

© Copyright 2013-2017 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.